New infection mechanism in coronavirus discovered
Results provide starting point for development of antiviral therapies
The research team led by Professor Dr. Dr. h.c. Ralf Bartenschlager, Head of the Division of Molecular Virology at the Center for Infectious Diseases at UKHD and Dr. Vibhu Prasad, Scientist in Molecular Virology has now analyzed the molecular pathways involved in SARS-CoV-2 infection of the cell. The cellular protein NUAK2 plays a central role in this process.
The Heidelberg scientists blocked NUAK2 in the cells and observed reduced infection of cells by SARS-CoV-2 particles. In subsequent studies, the scientists found that NUAK2 regulates the amount of ACE2, the receptor for the virus, on the cell surface. "In addition, our studies showed that increased NUAK2 levels in infected cells increased the number of receptors in uninfected cells as well. As a result, these cells also became more infected with SARS-CoV-2," reports Dr. Vibhu Prasad.
And these correlations could be demonstrated not only with SARS-CoV-2, but also with other coronavirus species such as human coronavirus-229E - a "common cold virus" - and the very dangerous MERS coronavirus, which can be transmitted from camels to humans.
"The research findings provide valuable insights into the intricate mechanisms of SARS-CoV-2 infection and spread. Understanding the role of NUAK2 opens new avenues for therapeutic intervention. By interrupting NUAK2-regulated virus entry, we might be able to prevent the spread of the virus and thereby mitigate the effects of coronavirus infections," says Professor Ralf Bartenschlager.
Original publication
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.